Grifols S.A. ADR (GRFS)
NGS · ADR · CUSIP E5706X132
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GRFS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
E5706X132 (prev. 874227101 )
Market Cap
Large Cap
ADR Ratio
.5:1
Business: Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. They accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care. They have three primary divisions -- Bioscience, Diagnostic and Hospital - which develop, produce and market their innovative products and services to medical professionals in more than 90 countries around the world.

Company Contact

CEO
José Ignacio Abia Buenache
CFO
Alfredo Arroyo Guerra
Investor Relations
investors@grifols.com
SEC EDGAR Filings
View filings »